JOSEPH DEFRAITES: Open Payments
NPI 1104381748 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,767 in 124 payments from 18 companies in 2025. Trend: 2023 $1,782 · 2024 $1,394 · 2025 $6,767
Food & beverage: $4,425Consulting: $2,088Travel & lodging: $254
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 27 | $3,135 |
| AstraZeneca Pharmaceuticals LP | 12 | $871 |
| GENZYME CORPORATION | 13 | $748 |
| GlaxoSmithKline, LLC. | 33 | $627 |
| Grifols USA, LLC | 9 | $267 |
| Viatris Specialty LLC | 4 | $194 |
| Insmed, Inc. | 4 | $174 |
| Verona Pharma, Inc. | 7 | $149 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $139 |
| Organon LLC | 1 | $138 |
Products named: DUPIXENT, NUCALA, BREZTRI, Prolastin-C Liquid, FASENRA, Arikayce, TEZSPIRE, Ohtuvayre.
Industry payments across LA — which companies pay providers there.
